Gastroduodenal reflux induces group IIa secretory phospholipase A2 expression and activity in murine esophagus

Diseases of the Esophagus

Volumn 23, Issue 5, 2010, Pages 430-436

  Mauchley, David ^a   Meng, Xianzhong ^a   Babu, Ashok ^a   Gamboni Robertson, Fabia ^a   Yang, Xiaoping ^a   Banerjee, Anirban ^a   Fullerton, David A ^a   Weyant, Michael J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Esophageal inflammation; Gastroduodenal reflux; Secretory phospholipase A2

Indexed keywords

MESSENGER RNA; SECRETORY PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 GROUP II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DUODENOGASTRIC REFLUX; ENZYME ACTIVITY; ESOPHAGITIS; ESOPHAGUS; ESOPHAGUS MUCOSA; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; LAPAROTOMY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE TO SIDE ANASTOMOSIS; STANDARDIZATION; STATISTICAL ANALYSIS; STUDENT T TEST; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GASTROESOPHAGEAL REFLUX; GENETICS; HYPERPLASIA; METABOLISM; MUCOSA; PATHOLOGY; REFLUX ESOPHAGITIS;

ANIMALS; DISEASE MODELS, ANIMAL; ESOPHAGITIS, PEPTIC; ESOPHAGUS; FLUORESCENT ANTIBODY TECHNIQUE; GASTROESOPHAGEAL REFLUX; GROUP II PHOSPHOLIPASES A2; HYPERPLASIA; MALE; MICE; MICE, INBRED BALB C; MUCOUS MEMBRANE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77954950781     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.01034.x     Document Type: Article

References (28)

1. Wild C, Hardie L. Reflux, Barrett's esophagus and adenocarcinoma: burning questions. Nat Rev Cancer 2003, 3:676-85.
2. Jemal A, Siegel R, Ward E. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
3. Altorki N. COX-2: a target for prevention and treatment of esophageal cancer. J Surg Res 2004, 117:114-20.
4. O'Riordan J M, Abdel-latif M M, Ravi N. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol 2005, 100:1257-64.
5. Eksteen J A, Scott P A, Perry I, Jankowski J A. Inflammation promotes Barrett's metaplasia and cancer: a unique role for TNFalpha. Eur J Cancer Prev 2001, 10:163-6.
6. Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 2002, 68(69):3-58.
7. Minami T, Tojo H, Shinomura Y, Matsuzawa Y, Okamoto M. Increased Group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut 1994, 35:1593-98.
8. Neidlinger N A, Hirvela E R, Skinner R A, Larkin S K, Harken A H, Kuypers F A. Postinjury serum secretory phospholipase A2 correlates with hypoxemia and clinical status at 72 hours. J Am Coll Surg 2005, 200:173-8.
9. Partrick D A, Moore E E, Silliman C C, Barnett C C, Kuypers F A. Secretory phospholipase A2 activity correlates with postinjury multiple organ failure. Crit Care Med 2001, 29:989-93.
10. Laye J P, Bill J H. Phospholipase A2 expression in tumors: a target for therapeutic intervention? Drug Discov Today 2003, 8:710-16.
11. Fijneman R J A, Cormier R T. The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine. Front Biosci 2008, 13:4144-74.
12. Lagorce-Pages C, Paraf F, Wendum D, Martin A, Flejou J F. Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus. Virchows Arch 2004, 444:426-35.
13. Kennedy B, Payette P, Mudgett J. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem 1995, 270:22378-85.
14. Babu A N, Meng X, Banerjee A. Secretory phospholipase A2 is required to produce histologic changes associated with gastroduodenal reflux in a murine model. J Thorac Cardiovasc Surg 2008, 135:1220-27.
15. Crowl R, Stoller T, Conroy R, Stoner C. Induction of Phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991, 266:2647-51.
16. Pfeilschifter J, Schalkwijk C, Briner V, van den Bosch H. Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. J Clin Invest 1993, 92:2516-23.
17. Kuwata H, Nakatani Y, Murakami M, Kudo I. Cytosolic Phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts. J Biol Chem 1998, 273:1733-40.
18. Fitzgerald R C, Onwuegbusi B A, Bajaj-Elliott M, Burnham W R, Farthing MJ. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 2002, 50:451-59.
19. Eerola L, Surrel F, Nevalainen T, Gelb M, Lambeau G, Laine V J. Analysis of expression of secreted phospholipases A2 in mouse tissues at protein and mRNA levels. Biochim Biophys Acta 2006, 1761:745-56.
20. Bidgood M, Jamal O, Cunningham A, Brooks P, Scott K. Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes. J Immunol 2000, 165:2790-97.
21. Wang D, Mann J, Dubois R. The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology 2005, 128:1445-61.
22. Wang D, Dubois R. Prostaglandins and cancer. Gut 2006, 55:115-22.
23. Buttar N, Wang K, Leontovich O. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 2002, 122:1101-12.
24. Zhang F, Altorki N, Wu Y, Soslow R, Subbaramaiah K, Dannenberg A. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 2001, 121:1391-9.
25. Buttar N, Wang K, Anderson M. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study. J Natl Cancer Inst 2002, 94:422-29.
26. Souza R, Shewmake K, Pearson S. Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 2004, 287:G743-8.
27. Wilson K, Fu S, Ramanujam K, Meltzer S. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998, 58:2929-34.
28. Ireland A P, Peters J H, Smyrk T C. Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg 1996, 223:358-62.